Arlington, MA, United States of America

Shyam K Singh


Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Natick, MA (US) (1997 - 2000)
  • Arlington, MA (US) (1997 - 2002)

Company Filing History:


Years Active: 1997-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Shyam K Singh in HIV Research

Introduction

Shyam K Singh is a notable inventor based in Arlington, MA (US), recognized for his significant contributions to medical research, particularly in the field of HIV treatment. With a total of four patents to his name, Singh has made strides in developing compounds that can potentially inhibit HIV infectivity.

Latest Patents

One of Singh's latest patents involves a compound for inhibiting HIV infectivity. This invention focuses on the discovery that condensation polymers of an aldehyde and aromatic sulfonic acids, such as formaldehyde naphthalenesulfonic acid condensation polymers, can effectively abrogate HIV gp120 binding to CD4. This has been demonstrated through CD4/gp120 binding assays. In addition to inhibiting gp120 binding, these compounds have shown the ability to inhibit HIV-induced syncytia formation and the infectivity of CD+ cells. Importantly, the use of this compound has been found to be non-cytotoxic and does not inhibit antigen-induced T lymphocyte proliferation. Based on these findings, these compounds hold promise as therapeutic agents for the treatment of acquired immunodeficiency syndrome (AIDS), AIDS-related complex (ARC), AIDS-related dementia, and non-symptomatic HIV infection. Furthermore, they can also be utilized to treat blood preparations.

Career Highlights

Shyam K Singh is currently associated with Procept Corporation, where he continues to innovate and contribute to the field of medical research. His work has garnered attention for its potential impact on HIV treatment and patient care.

Collaborations

Singh has collaborated with notable colleagues, including Raymond J Patch and Peter V Pallai, who share his commitment to advancing research in HIV and related fields.

Conclusion

Shyam K Singh's innovative work in developing compounds to inhibit HIV infectivity showcases his dedication to improving health outcomes for individuals affected by HIV. His contributions are paving the way for new therapeutic options in the fight against this disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…